Schrodinger, Inc.
SDGR
DELAYED 1 MONTH
16 insider filings · Latest: Mar 5, 2026
Common Stock Transactions
| Txn Date | Accepted | Insider | Type | Shares | Avg Price | Value | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|---|
| Mar 6, 2026 | Mar 6 10:29 PM | Jenny HermanCAO | Sale | 608 | $12.84 | $7.8K | 34,804(D) | View → |
| Mar 5, 2026 | Mar 6 10:29 PM | Jenny HermanCAO | Sale | 775 | $12.85 | $10.0K | 35,412(D) | View → |
| Mar 5, 2026 | Mar 6 10:29 PM | Rachit JainEVP & CFO | Sale | 1,631 | $12.90 | $21.0K | 52,596(D) | View → |
| Mar 5, 2026 | Mar 6 10:28 PM | Yvonne TranEVP, CLO & CPO | Sale | 1,094 | $12.90 | $14.1K | 52,683(D) | View → |
| Mar 5, 2026 | Mar 6 10:28 PM | Ramy FaridDirector, President & CEO | Sale | 3,661 | $12.91 | $47.2K | 330,824(D) | View → |
| Mar 5, 2026 | Mar 6 10:27 PM | Karen AkinsanyaPresident, Head of Therapeutics R&D and Chief Strategy Officer, Partnerships | Sale | 1,366 | $12.90 | $17.6K | 69,956(D) | View → |
| Mar 5, 2026 | Mar 6 10:26 PM | Kenneth Patrick LortonEVP, CTO & COO, Software | Sale | 1,222 | $12.90 | $15.8K | 89,241(D) | View → |
| Mar 4, 2026 | Mar 6 10:26 PM | Robert Lorne AbelEVP, Chief Scientific Officer, Platform | Sale | 1,300 | $12.81 | $16.7K | 55,897(D) | View → |
| Mar 2, 2026 | Mar 3 9:34 PM | Ramy FaridDirector, President & CEO | Sale | 5,560 | $11.90 | $66.2K | 334,485(D) | View → |
| Mar 2, 2026 | Mar 3 9:31 PM | Karen AkinsanyaPresident, Head of Therapeutics R&D and Chief Strategy Officer, Partnerships | Sale | 2,206 | $11.99 | $26.5K | 71,322(D) | View → |
Stock Options & Derivatives
| Txn Date | Accepted | Insider | Type | Shares | Exercise Price | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|
| Mar 2, 2026 | Mar 3 9:34 PM | Richard FriesnerDirector | Option Exercise | 160,527 | $3.07 | 0(D) | View → |
| Mar 2, 2026 | Mar 3 9:34 PM | Ramy FaridDirector, President & CEO | Grant/Award | 112,500 | $12.15 | 112,500(D) | View → |
| Mar 2, 2026 | Mar 3 9:33 PM | Rachit JainEVP & CFO | Grant/Award | 34,250 | $12.15 | 34,250(D) | View → |
| Mar 2, 2026 | Mar 3 9:33 PM | Yvonne TranEVP, CLO & CPO | Grant/Award | 34,250 | $12.15 | 34,250(D) | View → |
| Mar 2, 2026 | Mar 3 9:32 PM | Kenneth Patrick LortonEVP, CTO & COO, Software | Grant/Award | 34,250 | $12.15 | 34,250(D) | View → |
| Mar 2, 2026 | Mar 3 9:32 PM | Jenny HermanCAO | Grant/Award | 8,220 | $12.15 | 8,220(D) | View → |
| Mar 2, 2026 | Mar 3 9:31 PM | Karen AkinsanyaPresident, Head of Therapeutics R&D and Chief Strategy Officer, Partnerships | Grant/Award | 48,500 | $12.15 | 48,500(D) | View → |
| Mar 2, 2026 | Mar 3 9:31 PM | Mannix Vartan AklianEVP, Chief Commercial Officer, Global Head of Software Sales & Marketing | Grant/Award | 34,250 | $12.15 | 34,250(D) | View → |
| Mar 2, 2026 | Mar 3 9:30 PM | Robert Lorne AbelEVP, Chief Scientific Officer, Platform | Grant/Award | 34,250 | $12.15 | 34,250(D) | View → |